Dynamic Contrast Evaluation of the Liver Using Gadoxetate Disodium (Eovist®) for Hepatocellular Carcinoma (HCC)
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 4
- 主要终点
- Accuracy of a new MR protocol in diagnosing HCC and other liver lesions.
研究概览
简要总结
The purpose of this study is to determine if a new magnetic resonance (MR) protocol is better at diagnosing liver lesions.
详细描述
Hepatocellular carcinoma (HCC), a form of liver cancer, is the seventh most common cause of cancer mortality in the US. The incidence rate of HCC is increasing along with the incidence of Hepatitis B and C which are known to promote HCC. Patients have a better prognosis (survival outlook) if HCC is found and treated at an early stage. MRI is the best imaging modality for diagnosing HCC.
This study will compare standard MRIs and MRIs performed with a newly developed MR protocol to determine if it is possible to more confidently diagnose HCC.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •known hepatocellular carcinoma
- •undergoing MRI of the liver
排除标准
- •Contraindication to MRI with IV contrast
结局指标
主要结局
Accuracy of a new MR protocol in diagnosing HCC and other liver lesions.
时间窗: One day: participants will have one MRI of the liver.
次要结局
未报告次要终点